Answers are grounded in this paper and cite their sources.
Spinal cord injury (SCI) is a highly disabling central nervous system disorder. Tissue engineering strategies utilizing multifunctional hydrogels for neural stem cell (NSC) delivery represent a promising therapeutic direction for SCI. Herein, a temporally responsive dual-targeting multifunctional hydrogel (EnpMG-bSH) for NSC delivery is reported. An artificial intelligence (AI)-assisted designed TGF-β-targeted lysosome-targeting chimera (LYTAC) peptide EndoP144 is released in a temporally controlled manner in response to the gradually elevated matrix metalloproteinase-2 (MMP-2) in the SCI lesion site, enabling precise transforming growth factor-β (TGF-β) regulation. Adhesive silk fibroin nanoparticles anchored with si- Notch1 -loaded hybrid exosomes are incorporated to induce neuronal differentiation of NSCs, support synaptic remodeling and exert concurrent immunomodulatory effects. This system attenuates glial scarring by downregulating the TGF-β signaling pathway in astrocytes, modulates the differentiation of NSCs via targeted modulation of the Notch1 pathway, and reshapes the local inflammatory microenvironment toward an anti-inflammatory phenotype, significantly improving locomotor and sensory recovery in SCI mice. Collectively, the AI-assisted EnpMG-bSH hydrogel-NSCs complementary therapeutic strategy provides a potential framework for coordinated local treatment of SCI.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: